References
- WangSSunMPingQEnhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in ratsInt J Pharm20083581–219820418417306
- AsadaHDouenTWakiMAbsorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestineJ Pharm Sci19958466826877562404
- DunnS PCooneyGFKulinskyAAbsorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipientsTransplantation19956012143814428545871
- DeshmukhDDRavisWRBetageriG VImproved delivery of cromolyn from oral proliposomal beadsInt J Pharm20083581–212813618400424
- ZangBXJinMSiNZhangYWuWPiaoYZ[Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor]Yao Xue Xue Bao2002379696699 Chinese12567893
- ZhuHWangZMaCNeuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studiesPlanta Med200369542943312802724
- ChuDLiuWHuangZLiuSFuXLiuKPharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogsPlanta Med200672541842316557455
- QinFHuangXGuanxin II (II) for the management of coronary heart diseaseChin J Integr Med200915647247620082256
- LiuSXZhangYWangYFUpregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytesInt J Cardiol201216029510121497407
- QiJZhuangJWuWEnhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow AInt J Nanomedicine2011698599121720510
- LvLZTongCQLvQEnhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studiesInt J Nanomedicine201274099410722888246
- HuWDongHLiYZHuXTHanGJQuYBA high-throughput model for screening anti-tumor agents capable of promoting polymerization of tubulin in vitroActa Pharmacol Sin200425677578215169631
- BoukhettalaNClaeyssensSBensifiMEffects of essential amino acids or glutamine deprivation on intestinal permeability and protein synthesis in HCT-8 cells: involvement of GCN2 and mTOR pathwaysAmino Acids201242137538321113813
- MaTYNguyenDBuiVNguyenHHoaNEthanol modulation of intestinal epithelial tight junction barrierAm J Physiol19992764 Pt 1G965G97410198341
- DasSNgWKKanaujiaPKimSTanRBFormulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variablesColloids Surf B Biointerfaces201188148348921831615
- HuKCaoSHuFFengJEnhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluationInt J Nanomedicine201273537354522848177
- RogerEKalscheuerSKirtaneAFolic acid functionalized nanoparticles for enhanced oral drug deliveryPharmaceutics20129721032110
- TianYYangZFLiYPharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome ratsJ Ethnopharmacol201012911420206677
- SongLZhuYJinMZangBHydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cellsFitoterapia20138410711423160090
- SunLYangLXuY WNeuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/ nitration, 12/15-lipoxygenase and blood-brain barrier disruptionBrain Res2012147322723522867942
- ZhuHBZhangLWangZHTherapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanismsJ Asian Nat Prod Res20057460761316087635
- LiuLDuanJATangYTaoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregationJ Ethnopharmacol2012139238138722123200
- LevyMYBenitaSDrug release from submicronized o/w emulsion – a new in vitro kinetic evaluation modelInt J Pharm1990661–32937